Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

RedHill Biopharma (RDHL) Debt Ratio (2020 - 2022)

RedHill Biopharma has reported Debt Ratio over the past 3 years, most recently at 0.73 for Q4 2022.

  • Quarterly Debt Ratio fell 21.43% to 0.73 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 0.73 through Dec 2022, down 21.43% year-over-year, with the annual reading at 0.73 for FY2022, 21.43% down from the prior year.
  • Debt Ratio was 0.73 for Q4 2022 at RedHill Biopharma, roughly flat from 0.72 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.92 in Q4 2021 and troughed at 0.37 in Q1 2021.
  • The 3-year median for Debt Ratio is 0.51 (2022), against an average of 0.59.
  • Year-over-year, Debt Ratio crashed 31.18% in 2021 and then soared 61.61% in 2022.
  • A 3-year view of Debt Ratio shows it stood at 0.9 in 2020, then grew by 2.21% to 0.92 in 2021, then fell by 21.43% to 0.73 in 2022.
  • Per Business Quant, the three most recent readings for RDHL's Debt Ratio are 0.73 (Q4 2022), 0.72 (Q3 2022), and 0.51 (Q2 2022).